Trial of new oral drug against COVID-19 begins in South AfricaSouth Africa has been struggling with its plans to achieve the herd immunity through vaccinations, with widespread vaccine hesitancy, large...
Coronavirus may survive on surfaces longer in winterEven little heat could break the Covid virus down.
Potential Zika virus vaccine developedMicrocephaly is a birth defect where a baby's head is smaller than expected when compared to those of the same sex and age.
Review investment in non-core business: Govt to banksThe government has advised PSU banks to review their investments in different non-core banking activity and take suitable necessary decisio...
Cadila Pharma working on super-bug NDM-1; soon to commercialize India's first VLP vaccineRajiv Modi, Chairman and managing director of Cadila Pharmaceuticals Ltd said "The VLP technology flu vaccine would be commericialised with...
Cadila Pharma Chairman Indravadan Modi dies at 87Founder of Ahmedabad-based Cadila Pharmaceuticals, Indravadan Modi, better known as the octogenarian horse-riding chairman, passed away at ...
Cadila Pharma files for cancer vaccine patentCadila Pharmaceuticals has developed a cancer vaccine and has filed for its therapeutic patent with Controller General of Patents Designs a...
- Cadila Pharmaceuticals and Novavax to develop malaria vaccine using virus like particle technology
Cadila Pharma and Novavax to develop new malaria vaccine using VLP technology. ICGEB also to partner them in the project.
- Cadila Pharma signs pact with Bactiguard to sell products for prevention of hospital acquired infection
Bactiguard provides solutions preventing hospital acquired infections, which are the fourth largest cause of death in the western world.
- Zydus applies for Phase II & III H1N1 vaccine trials
The race amongst Indian swine flu vaccine-makers seems to be moving to the next level with Cadila Healthcare Ltd, the Rs 2,900-crore Zydus ...
- Gujarat gearing up with latest swine-flu vaccine
While Gujarat’s chief minister Narendra Modi is down with Swine Flu, the state will see a swine flu vaccine being developed using the most ...
- Cadila forms JV with US-based vaccine major Novavax
Ahmedabad-based Rs 800-crore Cadila Pharmaceuticals Ltd is all geared up for a large pie in the $665-million vaccine market in India.
- Our cancer drug will be another Polycap: IA Modi
At 84, IA Modi rides horses, travels in a Rolls Royce Phantom and dreams of blockbusters. The man who was all over the global medical journ...
- Novavax, Cadila form JV for developing vaccines
US-based biotechnology firm Novavax has formed a joint venture with Cadila Pharmaceuticals for developing and commercialising virus-like pa...